Literature DB >> 8018493

Possible pathogenic role of IgE in Henoch-Schönlein purpura.

J C Davin1, G Pierard, C Dechenne, D Grossman, J Nagy, M Quacoe, M Malaise, M Hall, F Jansen, J M Chantraine.   

Abstract

The incidences of clinical and biological markers of atopy were investigated in 16 children with IgA nephropathy (IgAN) (group A) and in 22 with Henoch-Schönlein purpura nephritis (HSPN) (group B). The incidence of increased plasma IgE levels according to age-matched normal values was significantly higher in group B (17/22, 77%) than in group A (7/16, 44%) (P < 0.05). Although not significant, the incidences of positive RAST tests and of a history of typical atopic symptoms were also higher in group B [10/22 (45%) and 11/22 (50%), respectively] than in group A [4/16 (25%) and 5/16 (31%), respectively]. Moreover, IgE deposits were demonstrated by a peroxidase/anti-peroxidase method on cutaneous Langerhans and mast cells in 4 of 6 patients with HSPN. Thus immunoallergy might account, in some cases, for the cutaneous, intestinal and pulmonary signs observed in HSPN, but not in IgAN. We postulate stimulation of IgE-sensitized mast cells by specific antigens in the presence of IgA circulating immune complexes (CIC), release of vasoactive substances, increased capillary permeability and perivascular deposition of IgA CIC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018493     DOI: 10.1007/bf00865470

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

1.  Special features in allergy in children.

Authors:  Z ERIKSSON-LIHR
Journal:  Acta Allergol       Date:  1955

2.  Allergic purpura, including purpura due to foods, drugs and infections.

Authors:  J F ACKROYD
Journal:  Am J Med       Date:  1953-05       Impact factor: 4.965

Review 3.  Mast cells as a source of multifunctional cytokines.

Authors:  J R Gordon; P R Burd; S J Galli
Journal:  Immunol Today       Date:  1990-12

Review 4.  Possible pathogenetic mechanisms in allergic cutaneous vasculitis.

Authors:  N Tosca; J D Stratigos
Journal:  Int J Dermatol       Date:  1988-06       Impact factor: 2.736

5.  A possible relationship between Henoch-Schonlein syndrome and IgA nephropathy (Berger's disease). An illustrative case.

Authors:  J H Weiss; D B Bhathena; J J Curtis; B A Lucas; R G Luke
Journal:  Nephron       Date:  1978       Impact factor: 2.847

6.  Alternate-pathway complement activation by IgA in Schoenlein-Henoch's syndrome.

Authors:  E H De la Faille-Kuyper; J S van der Meer; L Kater; N Mul
Journal:  Neth J Med       Date:  1974       Impact factor: 1.422

7.  Serum immunoglobulin E in atopic and non-atopic children aged 6 months to 5 years. A follow-up study.

Authors:  U M Saarinen; K Juntunen; M Kajosaari; F Björkstén
Journal:  Acta Paediatr Scand       Date:  1982-05

8.  Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of patients with leukocytoclastic angitis.

Authors:  I M Braverman; A Yen
Journal:  J Invest Dermatol       Date:  1975-02       Impact factor: 8.551

9.  Primary IgA glomerulonephritis and Schönlein-Henoch purpura nephritis: Clinicopathological and immunohistological characteristics.

Authors:  Y Nakamoto; Y Asano; K Dohi; M Fujioka; H Iida; H Kida; Y Kibe; N Hattori; J Takeuchi
Journal:  Q J Med       Date:  1978-10

10.  Occurrence of vascular IgA deposits in clinically normal skin of patients with renal disease.

Authors:  E H Faille-Kuyper; L Kater; R H Kuijten; C J Kooiker; S S Wagenaar; P van der Zouwen; E J Mees
Journal:  Kidney Int       Date:  1976-05       Impact factor: 10.612

View more
  15 in total

1.  Correlation of blood histamine levels with immunological indices in patients with Schönlein-Henoch purpura.

Authors:  A Belcheva; R Mishkova; E Mutafova
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

2.  Investigation of the change in CD4⁺ T cell subset in children with Henoch-Schonlein purpura.

Authors:  Yuan-Yuan Li; Cheng-Rong Li; Guo-Bing Wang; Jun Yang; Ying Zu
Journal:  Rheumatol Int       Date:  2011-12-21       Impact factor: 2.631

3.  Association between allergic diseases and risks of HSP and HSP nephritis: a population-based study.

Authors:  An-Chyi Chen; Cheng-Li Lin; Te-Chun Shen; Tsai-Chung Li; Fung-Chang Sung; Chang-Ching Wei
Journal:  Pediatr Res       Date:  2015-12-21       Impact factor: 3.756

Review 4.  The pathogenesis and treatment of pediatric Henoch-Schönlein purpura nephritis.

Authors:  Yukihiko Kawasaki
Journal:  Clin Exp Nephrol       Date:  2011-06-23       Impact factor: 2.801

5.  Childhood Henoch-Schönlein purpura nephritis and IgA nephropathy: one disease entity?--A clinico-pathologically comparative study.

Authors:  Jianhua Zhou; Aixia Huang; Tonglin Liu; Yujiu Kuang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 6.  Henoch-Schönlein purpura nephritis in children.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

7.  The role of chemokines in Henoch Schonlein Purpura.

Authors:  Fulya Tahan; Ismail Dursun; Hakan Poyrazoglu; Metin Gurgoze; Ruhan Dusunsel
Journal:  Rheumatol Int       Date:  2007-03-27       Impact factor: 3.580

8.  24h Urinary Protein Levels and Urine Protein/Creatinine Ratios Could Probably Forecast the Pathological Classification of HSPN.

Authors:  Qing Ye; Shi-Qiang Shang; Ai-Min Liu; Ting Zhang; Hong-Qiang Shen; Xue-Jun Chen; Jian-Hua Mao
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

9.  Relationship between immune parameters and organ involvement in children with Henoch-Schonlein purpura.

Authors:  Yan-xiang Pan; Qing Ye; Wen-xia Shao; Shi-qiang Shang; Jian-hua Mao; Ting Zhang; Hong-qiang Shen; Ning Zhao
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

Review 10.  Pathogenesis of Henoch-Schönlein purpura nephritis.

Authors:  Keith K Lau; Hitoshi Suzuki; Jan Novak; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2009-06-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.